Experts Call FDA's Device Approval Process Flawed
Experts urged U.S. House of Representatives members Thursday to change how the U.S. Food and Drug Administration grants marketing approval for the riskiest Class III medical devices, saying that abbreviated approval...To view the full article, register now.
Already a subscriber? Click here to view full article